In-stent restenosis (ISR) still represents a frequent limitation of percutaneous coronary intervention despite the introduction of latest-generation drug-eluting stents (DES), drastically lowering the overall incidence of ISR. Thus, the treatment of DES ISR remains a real brainteaser for interventional cardiologists.
Davide Piraino , Giuliana Cimino, Dario Buccheri, Giuseppe Andolina (2018). In-Stent Restenosis: Definition, Entity of the Problem, Etiopathogenesis and Treatment Options. In Textbook of Catheter-Based Cardiovascular Interventions (pp. 975-994). Springer [10.1007/978-3-319-55994-0_58].
In-Stent Restenosis: Definition, Entity of the Problem, Etiopathogenesis and Treatment Options
Davide Piraino
;CIMINO, Giuliana
;BUCCHERI, Dario
;
2018-01-01
Abstract
In-stent restenosis (ISR) still represents a frequent limitation of percutaneous coronary intervention despite the introduction of latest-generation drug-eluting stents (DES), drastically lowering the overall incidence of ISR. Thus, the treatment of DES ISR remains a real brainteaser for interventional cardiologists.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Piraino2018_Chapter_In-StentRestenosisDefinitionEn.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
582.54 kB
Formato
Adobe PDF
|
582.54 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
